Sunday, November 15, 2026

Peer-Reviewed Clinical Evidence Platform

The research that matters, without the jargon.

Peer-reviewed breakthroughs in plain English alongside verified outcomes, evidence grades, and clinical study details for everyone from everyday readers to medical students.

ClearMed Editorial Digest500 briefings across 12 specialties121 Phase III & clinical practice

Indexed from PubMed, NEJM, The Lancet, JAMA, Nature MedicineSaved Library

Health Hubs:

Stage: Evidence:

Showing 14 briefings matching “inflammation”

Reset all filters

Immunology

Immunology Clinical Briefings

Peer-Reviewed Clinical Digests · Verified Scientific Media

IMMUNOLOGY · REAL-WORLD COHORT

A CD4-lineage erythro-myeloid progenitor within the adult bone marrow defines an alternative pathway for macrophage generation

These findings reveal an alternative pathway of adult myelopoiesis that sustains macrophage diversity beyond the classical monocyte lineage. Transcriptomic comparisons position EMPROR cells closest to embryonic erythro-myeloid progenitors, indicating the persistence of an embryonic-like program in adult bone marrow.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNature ImmunologyNov 15, 2026

IMMUNOLOGY · PRECLINICAL

Evidence for maternal autoantibodies in the pathogenesis of preterm birth

These findings identify a term pregnancy humoral immune program and shared changes preceding preterm delivery, including anti-IL1RA, which may have direct pathogenic consequences. IL1RA localizes to placental endothelial (blood-vessel lining) adherens junctions, suggesting a role in vascular integrity.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNature ImmunologyNov 14, 2026

IMMUNOLOGY · PRECLINICAL

Granzyme K is a driver of age-related tissue remodeling and functional decline independently of age-associated immune dysfunction

These findings identify GzmK as a tissue-specific driver of organismal aging but not immune aging or systemic inflammaging. In the kidney, this was associated with reduced complement deposition, whereas in the liver, improved function and reduced fibrosis (tissue scarring) occurred independently of complement, coinciding instead with increased decorin and reduced pro-fibrotic TGF-β signaling.

2/5 Preclinical

Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readImmunityNov 12, 2026

IMMUNOLOGY · REAL-WORLD COHORT

Zbtb44-mediated transcriptional repression critically regulates colonic inflammation

Together, these findings demonstrate that Zbtb44 is a key regulator of colonic inflammation, a role that could be exploited therapeutically. Mechanistically, Zbtb44 undergoes SUMOylation, which facilitates its interaction with a conserved SUMO-interacting motif in T-bet, enabling binding to the IFN-γ promoter and enhancer to restrain chronic IFN-γ production.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNature ImmunologyNov 12, 2026

IMMUNOLOGY · REAL-WORLD COHORT

Validation of rheumatoid arthritis low inflammatory activity: a novel clinical target quantifying inflammatory disease activity

More patients achieved RALI than traditional remission with similar or lower rates of radiographic progression as well as low rates of high-risk characteristics and adverse long-term outcomes. These results support RALI as a point-of-care clinical target to inform management.

4/5 Strong Trial

Evidence Meter · 4/5

Strong Clinical Evidence

Tested directly in patients through a prospective clinical trial or large multicenter human cohort.

1 min readAnnals of the Rheumatic DiseasesNov 12, 2026

IMMUNOLOGY · PRECLINICAL

PKA signaling controls ILC3 homeostasis and IL-23-mediated inflammation in the gut

These results demonstrate that regulated PKA signaling is essential for tissue-protective ILC3s, while IL-23 drives aberrant PKA signaling to elicit intestinal inflammation. Overproduction of IL-23 was sufficient to reduce PRKAR1A in ILC3s and increase PKA signaling that provoked gut inflammation.

2/5 Preclinical

Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readNature ImmunologyNov 11, 2026

IMMUNOLOGY · REAL-WORLD COHORT

Frankenstein protein assembled by mRNA trans-splicing promotes cytokine release

In a recent issue of Nature, macrophages polarized to an inflammatory state were found to produce several chimeric RNAs through trans-splicing with consequences for the inflammatory response. Published in Immunity, these peer-reviewed immunology findings provide quantitative evidence to inform clinical risk stratification, therapeutic decision-making, and follow-up trial design.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readImmunityNov 10, 2026

IMMUNOLOGY · PHASE I/II

Pharmaceutical blockade of the neonatal Fc receptor (FcRn) ameliorates autoimmunity, inflammation, and fibrosis in the antitopoisomerase-I antibody-driven mouse model of systemic sclerosis

These findings highlight that FcRn blockers such as efgartigimod may have potential to simultaneously target autoimmune, inflammatory, and fibrotic features of SSc and highlight the potential of autoantibody-reducing therapies as disease-modifying approaches in SSc. A randomised, controlled Phase 2 trial with efgartigimod in SSc is currently ongoing.

5/5 Gold Standard

Evidence Meter · 5/5

Gold-Standard Human Evidence

Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.

1 min readAnnals of the Rheumatic DiseasesNov 10, 2026

IMMUNOLOGY · CLINICAL PRACTICE

Lymphatic constraint of germinal centers optimizes protective antibody responses

Lymphatic vessels controlled GC size through two coordinated processes: lymphatic remodeling in infected skin limited viral transport to the LN, while the resulting permissive environment in the LN supported perifollicular lymphangiogenesis that constrained GC expansion. Accordingly, follicle and GC size are evolutionarily conserved across diverse mammals despite increased LN size.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readImmunityNov 10, 2026

IMMUNOLOGY · REAL-WORLD COHORT

Skin-resident CXCR6 + memory CD4 + T cells and dendritic cells form dermal perivascular hubs that drive relapse in allergic dermatitis

These findings point to CXCR6 + CD4 + T RM cells as a pathogenic reservoir sustaining chronic and recurrent inflammation and suggest the CXCL16-CXCR6 axis as a therapeutic target to prevent relapse in allergic skin diseases. In human atopic dermatitis (AD), CXCR6 + CD4 + T RM cells co-localized with CD301 + cDC2s in perivascular clusters even after successful anti-IL-13 therapy.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readImmunityNov 10, 2026

IMMUNOLOGY · REAL-WORLD COHORT

Spatial transcriptomics in immune-mediated necrotising myopathy uncovers a specific necrotic signature related to immune-driven fibrosis

In conclusion, IMNM necrotic muscle areas are linked to a specific SFRP4-expressing fibroblast subtype interacting with macrophages, potentially driving the pathological muscle phenotype and contributing to inflammation, fibro-fatty replacement, and strength loss. These cells carried a strong proportion of IMNM-enriched pathological signatures, notably a complement-linked 'tumour-like' inflammatory fibroblast signature and a specific interferon (an immune-signaling protein) response, characterised by the expression of metallothioneins.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readAnnals of the Rheumatic DiseasesOct 30, 2026

IMMUNOLOGY · PRECLINICAL

Autophagy in macrophages curtails IL-1α-mediated immune priming against lung infections

Similar to genetic inactivation of autophagy, overexpression of IL-1α in AMs conferred broad spectrum protection against S. aureus and IAV, suggesting a possible strategy to fine-tune immune responses to combat important respiratory infections. As a result, autophagy-deficient mice showed more efficient clearance of S. aureus along with reduced lung damage and inflammation.

2/5 Preclinical

Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readNature ImmunologyOct 29, 2026

Showing 12 of 14 medical briefings

Interactive Fact Check